Patents
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
11/2006
11/15/2006EP1401434B1 Modulators of peroxisome proliferator activated receptors (ppar)
11/15/2006EP0968206B1 N-heterocyclic derivatives as nos inhibitors
11/15/2006CN1863800A Novel compounds that modulate PPAR type receptors, and use thereof in cosmetic or pharmaceutical compositions
11/15/2006CN1863791A Novel crystalline forms of {2-[1-(3,5-bis-trifluoromethylbenzyl)-5-pyridin-4-yl-1h-[1,2,3]triazol-4-yl]-pyridin-3-yl}-(2-chlorophenyl)-methanone
11/15/2006CN1863790A Therapeutic agents useful for treating pain
11/15/2006CN1863780A Protein kinase inhibitors and uses thereof
11/15/2006CN1863520A Alfavbeta3 and alfavbeta6 integrin antagonists as antifibrotic agents
11/15/2006CN1284785C Bivalent rare earth complex containing pyridine substituted indene ligand and its use
11/15/2006CN1284783C Substituted nitrogen contg. heterocycles as inhibitors of P38 progein kinase
11/15/2006CN1284773C Ortho-pyridinequinone derivative, composite containing said derivative, its preparation method and application
11/15/2006CN1284772C Benzamide kind histon deacetylase inhibiting agent having dissociation and antibred activity and its medicinal preparation
11/15/2006CN1284771C TNF-α生成抑制剂 TNF-α production inhibitor
11/14/2006US7135587 Such as 3-biphenyl-4-yl-3-(2-(3-(pyridin-2-ylamino)pro-poxycarbonylamino) -ethanoylamino)propionic acid; thromboses, cardiac infarction, coronary heart disease, arteriosclerosis, inflammation, tumors. osteoporosis, infections, restenosis
11/14/2006US7135574 Converting substituted mono or bicyclic lactones in presence of an amine base and a catalytic amount of a cyanide or alkali or alkaline metal alcoholate, to a salt, reacting the salt with carbonyl compound containing an organic substituent
11/14/2006US7135569 Process for the preparation of pyridinyl and pyrimidinyl mono-fluorinated beta keto-esters
11/14/2006US7135493 HDAC inhibitor
11/14/2006US7135487 Sulphonamide derivatives
11/14/2006US7135486 Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and the use thereof
11/14/2006US7135483 Substituted heterocyclic compounds for treating multidrug resistance
11/14/2006US7135478 Analogues of camptothecin, their use as medicaments and the pharmaceutical compositions containing them
11/14/2006US7135472 3-Heterocyclic benzylamide derivatives as potassium channel openers
11/14/2006CA2111386C Substituted benzoylguanidines, process for their preparation, their use as pharmaceutical or diagnostic, and pharmaceutical containing them
11/09/2006WO2006119390A1 Pyridines useful as modulators of ion channels
11/09/2006WO2006118155A1 Biphenyl derivative or salt thereof, and bactericide for agricultural and horticultural use containing same as active ingredient
11/09/2006WO2006117743A1 Substituted aromatic compounds as antidiabetic agents
11/09/2006WO2006117609A2 Phenoxypropylpiperidines and -pyrrolidines and their use as histamine h3 -receptor ligands
11/09/2006WO2006117549A1 Enzyme inhibitors
11/09/2006WO2006117048A1 Catalyst precursor for the production of olefins with an odd number of carbon atoms, process for its preparation and production method for such olefins
11/09/2006US20060252814 Formulation comprising a betablocker and optionally a cholestrol-lowering agent
11/09/2006US20060252798 Metal ion chelators and therapeutic use thereof
11/09/2006US20060252795 Chemokine receptor binding heterocyclic compounds
11/09/2006US20060252107 Compositions and methods for diagnosing and treating retinal diseases
11/09/2006DE102005019712A1 Dipyridyl-dihydropyrazolone und ihre Verwendung Dipyridyl dihydropyrazolones and their use
11/09/2006CA2606262A1 Novel histamine h3-receptor ligands and their therapeutic applications
11/09/2006CA2603818A1 Process for preparing 3,3-disubstituted oxindoles and thio-oxindoles
11/09/2006CA2599411A1 Enzyme inhibitors
11/08/2006EP1719763A1 Novel pyridine derivative and pyrimidine derivative (2)
11/08/2006EP1719762A1 Novel pyridine derivative and pyrimidine derivative (1)
11/08/2006EP1719748A2 Fluoranthene derivatives for use in organic electroluminescent devices
11/08/2006EP1718646A1 1,2,4-triazolo[4,3-a]pyridines useful in the treatment of gastrointestinal disorders
11/08/2006EP1718645A1 2-(pyridin-3-ylamino)-pyrido 2,3-d pyrimidin-7-ones
11/08/2006EP1718625A1 Compounds
11/08/2006EP1718614A1 Pyridinamide derivative as kinase inhibitors
11/08/2006EP1718613A1 Pyridine derivatives and their use as cb2 receptor modulators
11/08/2006EP1718342A1 Technetium-and rhenium-bis(heteroaryl) complexes, and methods of use thereof
11/08/2006EP1718335A2 Drug conjugates
11/08/2006EP1296716B1 Use of a beta-blocker for the treatment of atherosclerosis
11/08/2006EP1294691B1 Serine protease inhibitors
11/08/2006EP0993437B1 2-(4-bromo or 4-iodo phenylamino) benzoic acid derivatives and their use as mek inhibitors
11/08/2006CN1860097A Amide type carboxamide derivative
11/08/2006CN1859904A Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease
11/08/2006CN1283627C Process for preparing omega-mercapto-alkyl-pyridine
11/08/2006CN1283612C Process for producing 4-phenyl-4-oxo-2-butenoic ester derivative
11/07/2006US7132681 Electroluminescent iridium compounds with fluorinated phenylpyridines, phenylpyrimidines, and phenylquinolines and devices made with such compounds
11/07/2006US7132568 beta-amino amides; treating degenerative dementias characterized by beta-amyloid deposits in the brain, especially Alzheimer's Disease
11/07/2006US7132546 Aniline derivatives or salts thereof and cytokine production inhibitors containing the same
11/07/2006US7132544 Process for the preparation of tetrasubstituted imidazole derivatives and novel crystalline structures thereof
11/07/2006US7132445 Antiinflammatory agents; anticancer agents; analgesics; antiarthritic agents; inflammatory bowel disorders; respiratory system disorders
11/07/2006US7132425 5-substituted-six-membered heteroaromatic glucokinase activators
11/07/2006US7132422 An aromatic-oxy-alkyleneamine derivative, useful for treating neuropathic pain
11/07/2006US7132420 Aspartic protease inhibitors
11/07/2006CA2274093C Substituted pyrimidinone and pyridinone compounds and their use
11/07/2006CA2252515C Pharmaceutical compositions for prevention and treatment of central nervous system disorders
11/07/2006CA2130703C Diacyl-substituted guanidines, a process for their preparation, their use as medicine or diagnostic aid, and medicine containing them
11/02/2006WO2006116563A1 Vanilloid receptor ligands and their use in treatments
11/02/2006WO2006116007A2 Methods for synthesis of dicarbamate compounds and intermediates in the formation thereof
11/02/2006WO2006115652A1 Fluorinated pyridine n-oxide thrombin modulators and process for n-oxidation of nitrogen containing heteroaryls
11/02/2006WO2006115171A1 Method for producing nicotinic acid derivative or salt thereof
11/02/2006WO2006114264A1 Acetylene derivatives
11/02/2006WO2006114260A1 Phenylacetylene derivatives having mglur5 receptor affinity
11/02/2006WO2006114221A1 Sulfonylamino(thio)carbonyl compounds in the form of herbicides or plant growth regulators
11/02/2006WO2006097488A8 Use of n- (4-pyridyl) methylsulfonamides for combating arthropodal pests
11/02/2006WO2006069808A3 Nitro-substituted phenyl-piperazine compounds, their preparation and use in medicaments
11/02/2006WO2006061215A3 2-alkyl-cycloalk(en)yl-carboxamides
11/02/2006WO2006059149A8 Arylsulfonylnaphthalene derivatives as 5ht2a antagonists
11/02/2006WO2006047237A3 Heterocyclic indanone potentiators of metabotropic glutamate receptors
11/02/2006WO2005108349A3 Process for preparing atazanavir bisulfate and novel forms
11/02/2006US20060247297 Chiral arylketones in the treatment of neutrophil-dependent inflammatory diseases
11/02/2006US20060247289 Certain chemical entities, compositions, and methods
11/02/2006US20060247281 Process for halomethyl ethers of hydroxyiminomethyl quaternary pyridinium salts
11/02/2006US20060247280 Non-peptide, reversible inhibitors of type 2 methionine aminopeptidase, useful in treating conditions mediated by angiogenesis, such as cancer, haemangioma, proliferative retinopathy, rheumatoid arthritis, atherosclerotic neovascularization, psoriasis; 3-Benzyl-5-(benzylthio)-1,2,4-triazole
11/02/2006US20060247264 Modulators of the Glucocorticoid Receptor
11/02/2006US20060247260 Bis (hetero) aryl carboxamide derivatives for use as PG12 antagonists
11/02/2006US20060247259 Urea derivatives containing aromatic or heteroaromatic rings; 4-(3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7-methoxy-6-quinolinecarboxamide; prophylactic or therapeutic agent for a disease for which angiogenesis inhibition is effective
11/02/2006US20060247240 Method of treatment and/or prevention of brain, spinal or nerve injury
11/02/2006US20060247223 Non-imidazole alkylamines as histamine H3- receptor ligands and their therapeutic applications
11/02/2006US20060247186 Aryl urea compounds in combination with other cytostatic or cytotoxic agents for treating human cancers
11/02/2006US20060246102 N-'2-(2-pyridinyl) ethylbenzamide compounds and their use as fungicides
11/02/2006US20060246097 As compared with the conventional pyrithione metal salt, this complex compound exhibits superior bactericidal/fungicidal effects, newly realized a hair-regrowing effect and successfully attains improvement with respect to the solubility in seawater and thermal stability/weather resistance of polymers
11/02/2006EP1717356A1 Dast twin crystal, process for producing the same and use thereof
11/02/2006EP1717235A2 Phenoxypropylpiperidines and -pyrrolidines and their use as histamine H3-receptor ligands
11/02/2006EP1717234A1 Phenoxypropylpiperidines and -pyrrolidines and their use as histamine H3-receptor ligands
11/02/2006EP1717229A1 Novel cyclic compound having 4-pyridylalkylthio group having (un)substituted amino introduced therein
11/02/2006EP1717228A1 Sulfonylamino(thio)carbonylderivatives as herbicides or plant growth regulators
11/02/2006EP1717220A2 Vanilloid receptor ligands and their use in treatments
11/02/2006EP1716924A1 Catalyst precursor for the production of olefins with an odd number of carbon atoms, process for its preparation and production method for such olefins
11/02/2006EP1716851A1 Thioamides and salts thereof and cytokine production inhibitors containing both
11/02/2006EP1716130A1 Acetylinic piperazine compounds and their use as metabotropic glutamate receptor antagonists
11/02/2006EP1716120A1 Herbicidal heteroaroyl-substituted phenylalanine amides
11/02/2006EP1716117A1 Ionic uv-a sunscreens and compositions containing them